These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35281080)

  • 1. Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma.
    Zhang F; Liang J; Feng D; Liu S; Wu J; Tang Y; Liu Z; Lu Y; Wang X; Wei X
    Front Cell Dev Biol; 2022; 10():814735. PubMed ID: 35281080
    [No Abstract]   [Full Text] [Related]  

  • 2. A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma.
    Liu C; Wu Z; Wang L; Yang Q; Huang J; Huang J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Exploration of Tumor Microenvironment Modulation Based on the ESTIMATE Algorithm in Bladder Urothelial Carcinoma Microenvironment.
    Chen J; Lv B; Zhan Y; Zhu K; Zhang R; Chen B; Jin Y; Li Y; Zheng J; Lin C
    Front Oncol; 2022; 12():724261. PubMed ID: 35237505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.
    Luan JC; Zeng TY; Zhang QJ; Xia DR; Cong R; Yao LY; Song LB; Zhou X; Zhou X; Chen X; Xia JD; Song NH
    Cancer Cell Int; 2021 Aug; 21(1):414. PubMed ID: 34362387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated bioinformatics analysis identifies a Ferroptosis-related gene signature as prognosis model and potential therapeutic target of bladder cancer.
    Liu Z; Du D; Zhang S
    Toxicol Res (Camb); 2024 Feb; 13(1):tfae010. PubMed ID: 38292893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
    Zhang H; Song J; Dong J; Liu Z; Lin L; Wang B; Ma Q; Ma L
    Front Genet; 2021; 12():551605. PubMed ID: 33732281
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma.
    Zhou G; Qin G; Zhang Z; Zhao H; Xue L
    Front Immunol; 2023; 14():1283792. PubMed ID: 37954600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature.
    Li T; Jiang N; Bai Y; Liu T; Zhao Z; Xu X; Zhang Y; Wei F; Sun R; Liu S; Li J; Guo H; Yang R
    Heliyon; 2023 Mar; 9(3):e13661. PubMed ID: 36873527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer.
    Cai Y; Cheng Y; Wang Z; Li L; Qian Z; Xia W; Yu W
    BMC Cancer; 2023 Aug; 23(1):725. PubMed ID: 37543645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
    BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characteristics of bladder urothelial carcinoma subtypes.
    Li Y; Yang K; Li K; Liu H; Zhao S; Jiao M; Fu X
    J Cell Biochem; 2019 Jun; 120(6):9956-9963. PubMed ID: 30548659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer.
    Song X; Xin S; Zhang Y; Mao J; Duan C; Cui K; Chen L; Li F; Liu Z; Wang T; Liu J; Liu X; Song W
    Front Cell Dev Biol; 2022; 10():810272. PubMed ID: 35265613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis.
    Lin Y; Li T; Li Z; Shen C; Wu Z; Zhang Z; Li Z; Yang S; Wang Z; Li P; Fu C; Guo J; Hu H
    Front Genet; 2023; 14():1097179. PubMed ID: 37091788
    [No Abstract]   [Full Text] [Related]  

  • 17. A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma.
    Li X; Huang J; Chen J; Zhan Y; Zhang R; Lu E; Li C; Zhang Y; Wang Y; Li Y; Zheng J; Geng W
    Front Oncol; 2021; 11():726486. PubMed ID: 34966666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
    Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
    Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer.
    Zhao Z; Jiang N; Zhang Y; Bai Y; Liu T; Li T; Guo H; Yang R
    Front Genet; 2022; 13():919829. PubMed ID: 36246597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis.
    Xing P; Jiang Z; Liu Y
    BMC Cancer; 2022 Aug; 22(1):926. PubMed ID: 36030212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.